Cellcarta Is A Global Contract Research Organizationcrobased In Montrealcanadaspecializing In Precision Medicine Testing Servicesthe Company Integrates Expertise In Immunologyhistopathologyproteomicsand Genomics To Support Drug Development From Discovery Through Late Stage Clinical Trialsformed In 2019 From The Merger Of Caprion Biosciences And Histogenexcellcarta Has Expanded Through Acquisitionsestablishing A Presence In Canadathe U S Belgiumaustraliaand China Cellcarta Offers A Range Of Laboratory Testing And Biomarker Analysis Servicesincluding Immune Monitoringhistopathologyproteomicsand Genomicsthe Company Also Provides Specimen Logistics Through Cellcarta Logisticsensuring Global Sample Management And Transportationits Integrated Biomarker Testing Solutions Include Custom Assay Developmentdigital Pathology Platformsand Multi Omics Integrationcellcarta Partners With Biopharmaceutical Companies To Enhance Drug Development For Targeted Therapiesfocusing On Advancing Personalized Medicine By Identifying Biomarkers That Predict Patient Responses To Treatments
